Flunitazene: Difference between revisions
CSV import |
No edit summary |
||
| Line 26: | Line 26: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | <gallery> | ||
File:Fluonitazene structure.png|Flunitazene | File:Fluonitazene structure.png|Flunitazene | ||
</gallery> | </gallery> | ||
Latest revision as of 21:54, 16 March 2025
Flunitrazepam is a benzodiazepine derivative drug that is commonly known as a potent hypnotic, sedative, anxiolytic, amnestic, and skeletal muscle relaxant drug. It is marketed under various trade names worldwide, including Rohypnol, Flunipam, and Hypnodorm, among others.
Pharmacology[edit]
Flunitrazepam is a benzodiazepine agonist, which means it enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, resulting in sedative, sleep-inducing, anxiolytic, anticonvulsant, and muscle relaxant properties.
Medical Uses[edit]
Flunitrazepam is primarily used for the short-term treatment of insomnia. It is also used as a premedication for surgical procedures to induce sleepiness, reduce anxiety, and impair memory to prevent recall of the procedure.
Side Effects[edit]
Common side effects of flunitrazepam include drowsiness, impaired coordination, dizziness, and confusion. Long-term use can result in tolerance, physical dependence, and withdrawal syndrome. It may also cause paradoxical effects like increased anxiety, agitation, and hallucinations.
Legal Status[edit]
In many countries, flunitrazepam is a controlled substance, meaning its use is restricted due to its potential for abuse and addiction. In the United States, it is a Schedule IV controlled substance under the Controlled Substances Act.
See Also[edit]
-
Flunitazene
